The APHL-CDC Antimicrobial Resistance (AR) Fellowship Program provides scientists with the opportunity to collaborate on a range of antimicrobial resistance issues. The fellowship's mission is to introduce scientists to public health laboratory science while building the workforce needed to detect and respond to existing and emerging forms of AR.
The AR Fellowship is a full-time working fellowship program for master's- and doctoral-degree level scientists. Fellows will be placed in one of seven public health laboratories for a 12-month term. Extensions for an additional 12-month term may be granted, provided funding is available. In addition to laboratory-specific work, fellows will participate in distance-based training and learning activities to achieve proficiency in select public health laboratory core competencies.
There are currently two AR Fellowship tracks offered. Prospective fellows are welcome to apply to one or both tracks.
Drug-Resistant Tuberculosis Track
Multidrug-resistant Tuberculosis (MDR-TB) is a disease of grave domestic and global public health concern. Rapid and accurate identification of drug resistance is imperative both to ensure appropriate treatment for individual patients as well as the administration of necessary TB Control measures. Fellows participating in the TB Track work with public health leaders to perform and apply conventional, culture-based and cutting edge, molecular methods to identify and control drug resistant TB outbreaks. The fellow will be primarily placed at the Michigan Department of Health and Human Services Bureau of Laboratories and will complete periodic rotations at CDC and other public health laboratories.
Host Laboratories are pre-selected by APHL, so there is no open call for host laboratories at this time.
Fellows receive a stipend and allowances for: medical insurance, travel to the host laboratory, professional development, training at CDC, and; complimentary student membership to APHL. The 2019 stipend follows the federal General Schedule (GS) pay table. Post-masters will receive compensation commensurate to GS-9 step 1 and post-doctoral fellows receiving compensation commensurate to GS-11 step 1.
Applicants must be US citizens or permanent residents. Applicants must have completed a master's or doctoral degree in microbiology, molecular biology, or a related discipline by the start date of the fellowship.
The online application includes submission of a narrative statement, resume or CV, three le tters of recommendation, official transcripts from all degree-granting institutions, and proof of US citizenship or permanent residency. It is the responsibility of the applicant to ensure all materials are received by APHL by the application deadline. Applications that are incomplete or received after the deadline will not be considered. Finalists will be invited to interview with host laboratories.
November 1, 2018
Online applications available for prospective fellows
February 28, 2019
Deadline for receipt of application and supplemental materials to APHL
April 15, 2019
All applicants notified of status. Finalists invited to interview
April – May 2019
Fellows report to host laboratories and begin fellowship
Meet the Antimicrobial Resistance Fellows!
APHL-CDC Antimicrobial Resistance Fellows are selected from a highly competitive pool of applicants. Learn more about the current Fel lows .
View a list of FAQs about the program and the application process . If you have additional questions, please contact Nikki Marchan , MPH, specialist, Antimicrobial Resistance, or Kelly Wroblewski, MPH, MT(ASCP), director, Infectious Disease Programs .